Item 5.07 Submission of Matters to a Vote of Security Holders.
At the 2026 Annual Meeting of Stockholders of Twist Bioscience Corporation (the "Company"), there were present, in person or by proxy, holders of 56,260,506 shares of common stock, or approximately 91.81% of the total outstanding shares eligible to be voted. The holders present voted on the three proposals presented at the Annual Meeting as follows.
Proposal One - Election of Directors
The Company's stockholders approved the election of three directors to the Company's Board of Directors as Class II Directors to serve for the ensuing three years and until their successors are elected and qualified or until their earlier resignation or removal, by the following votes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
Votes For
|
|
Votes Withheld
|
|
Broker Non-Votes
|
|
Keith Crandell
|
|
40,500,506
|
|
9,805,197
|
|
5,954,803
|
|
Jan Johannessen
|
|
42,319,597
|
|
7,986,106
|
|
5,954,803
|
|
Trynka Shineman Blake
|
|
50,217,493
|
|
88,210
|
|
5,954,803
|
Proposal Two - Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")
The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs, by the following votes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
|
38,430,673
|
|
11,842,367
|
|
32,663
|
|
5,954,803
|
Proposal Three - Ratification of Appointment of Independent Registered Accounting Firm
The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2026, by the following votes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes For
|
Votes Against
|
Abstentions
|
|
56,220,551
|
|
18,170
|
|
21,785
|